Australia markets closed

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.28-0.21 (-1.14%)
As of 12:08PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
301,908
353,314
41,333
37,977
Cost of revenue
123,243
90,565
415
180,238
Gross profit
178,665
262,749
40,918
-142,261
Operating expenses
Research development
599,355
604,081
561,423
438,215
Selling general and administrative
684,455
488,026
67,881
78,001
Total operating expenses
1,320,924
1,091,505
628,860
515,586
Operating income or loss
-1,142,259
-828,756
-587,942
-657,847
Interest expense
3,391
2,895
3,205
15,080
Total other income/expenses net
37,568
-4,068
9,242
1,313,692
Income before tax
-1,112,887
-839,653
-576,677
625,056
Income tax expense
5,546
7,076
-5,136
43,774
Income from continuing operations
-1,118,433
-846,729
-571,541
581,282
Net income
-1,118,433
-846,729
-571,541
581,282
Net income available to common shareholders
-1,118,433
-846,729
-571,541
581,282
Basic EPS
-
-22.07
-16.91
18.94
Diluted EPS
-
-22.07
-16.91
18.94
Basic average shares
-
38,370
33,802
30,691
Diluted average shares
-
38,370
33,802
30,696
EBITDA
-
-794,066
-559,790
644,644